Pharmaceutical Executive December 12, 2024
Miranda Schmalfuhs

The latest news for pharma industry insiders.

Trade & Channel Strategies 2024: Access and Channel 2024 Year-in-Review and Preview of 2025

This year’s Trade & Channel Strategies Conference in Philadelphia kicked off with a keynote address from Bill Roth, SVP of IntegriChain’s consulting business, Blue Fin Group, and Pharma Commerce board member. Titled “Access and Channel 2024 Year-in-Review and Preview of 2025”, Roth discussed the current reimbursement landscape, how the evolving site-of-care trends are shaping patient access and channel dynamics, and the influence of cost of goods on channel strategies and profitability.

ASHP Midyear: High Costs of Gene Therapies Present Major Challenges to Implementation

According to the report, 75% of survey participants expect pharmacists to oversee these therapies and 58%...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Related Articles:
Mark Cuban: A Master Disrupter for American Healthcare
Despite Trump’s Tough Talk On PBMs, GOP House Lets Them Off The Hook
How has U.S. Spending on Health Care Changed Over Time?
Bringing genomics closer to patients: 3 takeaways from Henry Ford Health
Merck enters $2B licensing deal for weight loss drug

Share This Article